The vaccine should be administered intramuscularly, for younger children - in the thigh area, for older children - in the deltoid muscle. It is strictly forbidden to administer the vaccine intravenously, subcutaneously and intradermally.
Before vaccination, it is recommended to examine the child and exclude contact with SARS patients.
Patients should be under medical supervision for 30 minutes after administration of the vaccine.
Vaccine for primary immunization of infants and young children, starting from 6 weeks of age, for the prevention of:
It is also used for revaccination.
Hypersensitivity to any component of the vaccine or reaction to the pertussis component, if a neurological complication has been detected after previous vaccination. Vaccination is not given to children who have a history of:
After vaccination can be observed:
In the presence of mechanical inclusions or a strange color of the suspension, the use of the vaccine is unacceptable.